The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Pharmaceuticals in the environment: scientific evidence of risks and its regulation
Open accessAbstract
During the past two decades scientists, regulatory agencies and the European Commission have acknowledged pharmaceuticals to be an emerging environmental problem. In parallel, a regulatory framework for environmental risk assessment (ERA) of pharmaceutical products has been developed. Since the regulatory guidelines came into force the German Federal Agency (UBA) has been evaluating ERAs for human and veterinary pharmaceutical products before they are marketed. The results show that approximately 10% of pharmaceutical products are of note regarding their potential environmental risk. For human medicinal products, hormones, antibiotics, analgesics, antidepressants and antineoplastics indicated an environmental risk. For veterinary products, hormones, antibiotics and parasiticides were most often discussed as being environmentally relevant. These results are in good correlation with the results within the open scientific literature of prioritization approaches for pharmaceuticals in the environment. UBA results revealed that prospective approaches, such as ERA of pharmaceuticals, play an important role in minimizing problems caused by pharmaceuticals in the environment. However, the regulatory ERA framework could be improved by (i) inclusion of the environment in the risk–benefit analysis for human pharmaceuticals, (ii) improvement of risk management options, (iii) generation of data on existing pharmaceuticals, and (iv) improving the availability of ERA data. In addition, more general and integrative steps of regulation, legislation and research have been developed and are presented in this article. In order to minimize the quantity of pharmaceuticals in the environment these should aim to (i) improve the existing legislation for pharmaceuticals, (ii) prioritize pharmaceuticals in the environment and (iii) improve the availability and collection of pharmaceutical data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Widespread Sexual Disruption in Wild Fish
Jobling, S., Nolan, M., Tyler, C. R., Brighty, G., & Sumpter, J. P. (1998) · Environmental Science & Technology · doi:10.1021/es9710870 · Cited by 2,002
Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China
Liu, J.-L., & Wong, M.-H. (2013) · Environment International · doi:10.1016/j.envint.2013.06.012 · Cited by 1,357
Loos, R., Carvalho, R., António, D. C., Comero, S., Locoro, G., Tavazzi, S., Paracchini, B., Ghiani, M., Lettieri, T., Blaha, L., et al. (2013) · Water Research · doi:10.1016/j.watres.2013.08.024 · Cited by 1,193
Dilute Concentrations of a Psychiatric Drug Alter Behavior of Fish from Natural Populations
Brodin, T., Fick, J., Jonsson, M., & Klaminder, J. (2013) · Science · doi:10.1126/science.1226850 · Cited by 850
Metcalfe, C. D., Chu, S., Judt, C., Li, H., Oakes, K. D., Servos, M. R., & Andrews, D. M. (2010) · Environmental Toxicology and Chemistry · doi:10.1002/etc.27 · Cited by 504
Determination of pKa values of active pharmaceutical ingredients
Babić, S., Horvat, A. J. M., Mutavdžić Pavlović, D., & Kaštelan-Macan, M. (2007) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2007.09.004 · Cited by 500
Kostich, M. S., Batt, A. L., & Lazorchak, J. M. (2014) · Environmental Pollution · doi:10.1016/j.envpol.2013.09.013 · Cited by 466
Nakamura, Y., Yamamoto, H., Sekizawa, J., Kondo, T., Hirai, N., & Tatarazako, N. (2008) · Chemosphere · doi:10.1016/j.chemosphere.2007.06.089 · Cited by 259
Brausch, J. M., Connors, K. A., Brooks, B. W., & Rand, G. M. (2012) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-1-4614-3137-4_1 · Cited by 258
Christen, V., Hickmann, S., Rechenberg, B., & Fent, K. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2009.11.021 · Cited by 222
Cited by
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., & Mohan, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00299 · Cited by 2,654
Pharmaceuticals in the environment-global occurrences and perspectives
aus der Beek, T., Weber, F.-A., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., & Küster, A. (2015) · Environmental Toxicology and Chemistry · doi:10.1002/etc.3339 · Cited by 1,595
Self-citationAntibiotics in the environment: causes and consequences
Polianciuc, S. I., Gurzău, A. E., Kiss, B., Ștefan, M. G., & Loghin, F. (2020) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1742 · Cited by 692
Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems
Arnold, K. E., Brown, A. R., Ankley, G. T., & Sumpter, J. P. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0569 · Cited by 441
Chiral pharmaceuticals: A review on their environmental occurrence and fate processes
Sanganyado, E., Lu, Z., Fu, Q., Schlenk, D., & Gan, J. (2017) · Water Research · doi:10.1016/j.watres.2017.08.003 · Cited by 292
Metadata
- Authors
- Küster, A., & Adler, N.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2014-11-19
- Volume
- 369
- Issue
- 1656
- Pages
- 20130587
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2114800327
- Cited by
- 370
- References
- 17
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmaceuticals in the environment: scientific evidence of risks and its regulation. https://app.cochat.ai/papers/10.1098/rstb.2013.0587
- The paper
- Küster, A., & Adler, N. (2014). Pharmaceuticals in the environment: scientific evidence of risks and its regulation. Philosophical Transactions of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rstb.2013.0587
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.